Your search returned 2 results.

Results
	1.	Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. [electronic resource] by Keystone, Edward Fleischmann, Roy Emery, Paul Furst, Daniel E van Vollenhoven, Ronald Bathon, Joan Dougados, Maxime Baldassare, Andrew Ferraccioli, Gianfranco Chubick, Andrew Udell, James Cravets, Matthew W Agarwal, Sunil Cooper, Simon Magrini, Fabio Producer: 20080207 In: Arthritis and rheumatism vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. [electronic resource] by Cohen, Stanley B Emery, Paul Greenwald, Maria W Dougados, Maxime Furie, Richard A Genovese, Mark C Keystone, Edward C Loveless, James E Burmester, Gerd-Rüdiger Cravets, Matthew W Hessey, Eva W Shaw, Timothy Totoritis, Mark C Producer: 20061108 In: Arthritis and rheumatism vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search